tradingkey.logo

tradingkey.logo
怜玢


Enovis Corp

ENOV
りォッチリストに远加
24.290USD
-1.820-6.97%
終倀 05/15, 16:00ET15分遅れの株䟡
1.40B時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Enovis Corp 䌁業名

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Enovis Corpの䌁業情報


䌁業コヌドENOV
䌚瀟名Enovis Corp
䞊堎日May 08, 2008
最高経営責任者「CEO」Mcdonald (Damien)
埓業員数7367
蚌刞皮類Ordinary Share
決算期末May 08
本瀟所圚地2711 Centerville Road
郜垂WILMINGTON
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号19808
電話番号13022529160
りェブサむトhttps://www.enovis.com/
䌁業コヌドENOV
䞊堎日May 08, 2008
最高経営責任者「CEO」Mcdonald (Damien)

Enovis Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
32.60K
+13.31%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
18.11K
-12.48%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
13.01K
-17.38%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
9.03K
-16.51%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
8.26K
-27.37%
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
Ms. Patricia A. Lang
Ms. Patricia A. Lang
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
32.60K
+13.31%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
18.11K
-12.48%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
13.01K
-17.38%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
9.03K
-16.51%

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
䌚瀟名
収益
比率
Medical Technology-Prevention & Rehabilitation
1.14B
50.58%
Medical Technology-Reconstructive
1.11B
49.42%
地域別USD
䌚瀟名
収益
比率
United States
1.30B
57.62%
Other Foreign locations
952.72M
42.38%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Medical Technology-Prevention & Rehabilitation
1.14B
50.58%
Medical Technology-Reconstructive
1.11B
49.42%

株䞻

曎新時刻: Thu, May 14
曎新時刻: Thu, May 14
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
BlackRock Institutional Trust Company, N.A.
14.02%
American Century Investment Management, Inc.
9.14%
Vanguard Portfolio Management, LLC
6.62%
Vanguard Capital Management, LLC
4.43%
Dimensional Fund Advisors, L.P.
4.42%
他の
61.37%
株䞻統蚈
株䞻統蚈
比率
BlackRock Institutional Trust Company, N.A.
14.02%
American Century Investment Management, Inc.
9.14%
Vanguard Portfolio Management, LLC
6.62%
Vanguard Capital Management, LLC
4.43%
Dimensional Fund Advisors, L.P.
4.42%
他の
61.37%
皮類
株䞻統蚈
比率
Investment Advisor
66.66%
Investment Advisor/Hedge Fund
28.44%
Hedge Fund
17.41%
Research Firm
5.91%
Individual Investor
1.53%
Bank and Trust
1.19%
Pension Fund
1.14%
Venture Capital
0.04%
Insurance Company
0.03%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
652
68.97M
119.81%
-6.76M
2025Q4
617
68.12M
125.63%
--
2025Q3
641
68.12M
128.26%
-1.19M
2025Q2
651
69.44M
130.24%
+2.07M
2025Q1
629
67.38M
125.09%
-4.06M
2024Q4
625
63.48M
125.04%
+1.28M
2024Q3
599
62.09M
124.13%
-57.94K
2024Q2
602
61.71M
121.92%
+2.05M
2024Q1
635
59.58M
125.47%
-9.23M
2023Q4
647
58.62M
120.02%
+2.97M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
BlackRock Institutional Trust Company, N.A.
8.07M
14.1%
+110.96K
+1.39%
Dec 31, 2025
American Century Investment Management, Inc.
5.26M
9.19%
+528.25K
+11.17%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.78M
4.86%
-189.61K
-6.38%
Dec 31, 2025
Rubric Capital Management LP
2.45M
4.29%
-296.74K
-10.79%
Dec 31, 2025
Davenport Asset Management
2.44M
4.26%
-367.69K
-13.10%
Dec 31, 2025
State Street Investment Management (US)
2.37M
4.14%
+20.61K
+0.88%
Dec 31, 2025
Dorsey Asset Management LLC
2.28M
3.98%
-120.12K
-5.01%
Dec 31, 2025
Fidelity Management & Research Company LLC
1.93M
3.37%
+665.45K
+52.61%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
State Street SPDR S&P Health Care Equipment ETF
1.83%
Invesco S&P SmallCap Health Care ETF
1.09%
Invesco S&P SmallCap 600 Pure Value ETF
0.45%
State Street SPDR S&P 600 Small Cap Value ETF
0.25%
iShares S&P Small-Cap 600 Value ETF
0.24%
iShares U.S. Medical Devices ETF
0.21%
Humankind US Stock ETF
0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
0.18%
Avantis US Small Cap Equity ETF
0.18%
Invesco S&P SmallCap 600 Revenue ETF
0.16%
詳现を芋る
State Street SPDR S&P Health Care Equipment ETF
比率1.83%
Invesco S&P SmallCap Health Care ETF
比率1.09%
Invesco S&P SmallCap 600 Pure Value ETF
比率0.45%
State Street SPDR S&P 600 Small Cap Value ETF
比率0.25%
iShares S&P Small-Cap 600 Value ETF
比率0.24%
iShares U.S. Medical Devices ETF
比率0.21%
Humankind US Stock ETF
比率0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
比率0.18%
Avantis US Small Cap Equity ETF
比率0.18%
Invesco S&P SmallCap 600 Revenue ETF
比率0.16%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
日付
配圓萜ち日
皮類
比率
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
KeyAI
î™